Zusammenfassung
Die hepatische Enzephalopathie (HE) ist eine der häufigsten Komplikationen der Leberzirrhose. Im vorliegenden Beitrag werden die klinische Symptomatik, die Pathophysiologie, die Diagnosestellung und die Differenzialdiagnose sowie die Therapie der hepatischen Enzephalopathie beschrieben. Zusätzlich wird auf die Bedeutung der sog. minimalen hepatischen Enzephalopathie eingegangen und deren Diagnostik erläutert.
Abstract
Hepatic encephalopathy (HE) is one of the most frequent complications of liver cirrhosis. The present article describes (1) the clinical features, (2) pathophysiology, (3) diagnosis and differential diagnosis, and (4) therapy of HE in patients with cirrhosis. In addition the clinical meaning and diagnosis of so-called minimal HE is addressed.
Literatur
Ahl B, Weissenborn K, Hoff J van den et al (2004) Regional differences in cerebral blood flow and cerebral ammonia metabolism in patients with cirrhosis. Hepatology 40:73–79
Bajaj JS, Saeian K, Schubert CM et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50:1175–1183
Bass NM, Mullen KD, Sanyal A et al (2010) Rifaximin treatment in hepatic encephalopathy. N Engl J Med 362:1071–1081
Butterworth RF, Spahr L, Fontaine S et al (1995) Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab Brain Dis 10(4):259–27
Conn HO, Lieberthal MM (1978) Assessment of mental state. In: Conn HO, Lieberthal MM (Hrsg) The hepatic coma syndromes and lactulose. Williams & Wilkins, Baltimore, S 169–188
Cordoba J, Lopez-Hellin J, Planas M et al (2004) Normal protein diet for episodic hepatic encephalopathy: results of a randomized study. J Hepatol 41:38–43
Dhiman RK, Kurmi R, Thumburu KK et al (2010) Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8):2381–2390
Ferenci P, Lockwood A, Mullen K et al (2002) Hepatic encephalopathy – definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
Groeneweg M, Quero JC, De Bruijn I et al (1988) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49
Häussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156–1165
Jayakumar AR, Rama Rao KV, Kalaiselvi P et al (2004) Combined effects of ammonia and manganese on astrocytes in culture. Neurochem Res 29(11):2051–2056
Jepsen P, Ott P, Andersen PK et al (2010) Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology 51:1675–1682
Kale RA, Gupta RK, Saraswat VA et al (2006) Demonstration of interstitial cerebral edema with diffusion tensor MR imaging in type C hepatic encephalopathy. Hepatology 43:698–706
Kircheis G, Wettstein M, Timmermann L et al (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35:357–366
Kircheis G, Knoche A, Hilger N et al (2009) Hepatic encephalopathy and fitness to drive. Gastroenterology 137:1706–1715
Krieger S, Jauß M, Jansen O et al (1996) Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111:147–155
Lockwood AH, Weissenborn K, Butterworth RF (1997) An image of the brain in patients with liver disease. Curr Opin Neurol 10(6):525–533
Lockwood AH (2000) What’s in a name? Improving the care of cirrhotics. J Hepatol 32:859–861
Marchesini G, Bianchi G, Merli M et al (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801
Muto Y, Sato S, Watanabe A et al (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713
Plum F, Hindfelt B (1976) The neurological complications of liver disease. In: Vinken P, Bruyn DF (Hrsg) Handbook of clinical neurology, Bd 27. Elsevier, Amsterdam, S 349–377
Prasad S, Dhiman RK, Duseja A et al (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45(3):549–559
Quadri AM, Ogunwale BO, Mullen KD (2007) Can we ignore minimal hepatic encephalopathy any longer? Hepatology 45:547–548
Randolph C, Hilsabeck R, Kato A et al (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):629–635
Read A, Sherlock S, Laidlaw J et al (1967) The neuro-psychiatric syndromes associated with chronic liver disease and an extensive portal-systemic collateral circulation. Q J Med XXXVI(114):135–150
Rose C, Butterworth RF, Zayed J et al (1999) Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117:640–644
Schomerus H, Hamster W, Blunck H et al (1981) Latent portasystemic encephalopathy: I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26:622–630
Schomerus H, Weissenborn K, Hamster W et al (1999) PSE-Syndrom-Test. Swets Test Services. Swets & Zeitlinger B.V, Frankfurt
Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13(4):361–377
Sharma BC, Sharma P, Agarwal A et al (2009) Secondary prophylaxis of hepatic encephalopathy: an open label randomized controlled trial of lactulose versus placebo. Gastroenterology 137:885–891
Shawcross DL, Balata S, Olde-Damink SW et al (2004) Low myoinositol and high glutamine levels in brain are associated with neuropsychological deterioration after induced hyperammonemia. Am J Physiol 287:G503–G509
Uribe M, Campollo O, Vargas F et al (1987) Acidifying enemas (lactitol and lactose) vs. nonacidifying enemas (tap water) to treat acute portal-systemic encephalopathy: a double-blind randomized clinical trial. Hepatology 7:639–643
Wein C, Koch H, Popp B et al (2004) Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39:739–745
Weissenborn K (1991) Neurophysiological methods in the diagnosis of early hepatic encephalopathy. In: Bengtsson F, Jeppsson B, Almdal T, Vilstrup H (Hrsg) Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boca Raton, S 27–39
Weissenborn K, Ennen J, Schomerus H et al (2001) Neuropsychological characterisation of hepatic encephalopathy. J Hepatol 34(5):768–773
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tryc, A., Goldbecker, A. & Weissenborn, K. Hepatische Enzephalopathie. Intensivmed 47, 553–558 (2010). https://doi.org/10.1007/s00390-010-0189-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00390-010-0189-y
Schlüsselwörter
- Leberzirrhose
- Hepatische Enzephalopathie
- Minimale hepatische Enzephalopathie
- Hepatische Myelopathie
- Erworbene hepatolentikuläre Degeneration